NON-VALVULAR ATRIAL FIBRILLATION
Clinical trials for NON-VALVULAR ATRIAL FIBRILLATION explained in plain language.
Never miss a new study
Get alerted when new NON-VALVULAR ATRIAL FIBRILLATION trials appear
Sign up with your email to follow new studies for NON-VALVULAR ATRIAL FIBRILLATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Tiny heart plug aims to stop killer strokes
Disease control OngoingThis early study is testing a new heart implant called the CLAAS device. It is designed for people with atrial fibrillation (AFib) who are at high risk of stroke but cannot take long-term blood thinners. The device is placed to seal off a small pouch in the heart where dangerous …
Matched conditions: NON-VALVULAR ATRIAL FIBRILLATION
Phase: NA • Sponsor: Conformal Medical, Inc • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
New heart plug aims to stop strokes without blood thinners
Disease control OngoingThis study is testing a small, permanent heart implant called the Omega™ LAA Occluder. It is designed for people with a common heart rhythm problem (atrial fibrillation) who are at high risk for strokes but also have a high risk of dangerous bleeding, which prevents them from saf…
Matched conditions: NON-VALVULAR ATRIAL FIBRILLATION
Phase: NA • Sponsor: Eclipse Medical Ltd. • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
New heart implant aims to stop deadly strokes before they happen
Disease control TerminatedThis study is testing a new heart implant device designed to prevent strokes in people with a common heart rhythm problem called atrial fibrillation. The device seals off a small pouch in the heart where blood clots often form. Researchers will compare this new device to two alre…
Matched conditions: NON-VALVULAR ATRIAL FIBRILLATION
Phase: NA • Sponsor: Biosense Webster, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
New heart device could offer lifeline for Stroke-Prone patients
Disease control OngoingThis early study is testing a small heart implant called the Laminar device. It aims to prevent strokes in people with a common heart rhythm problem (atrial fibrillation) who cannot safely take long-term blood thinners. Doctors will implant the device to seal off a small pouch in…
Matched conditions: NON-VALVULAR ATRIAL FIBRILLATION
Phase: NA • Sponsor: Biosense Webster, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC